Copyright
©The Author(s) 2019.
World J Gastroenterol. Mar 21, 2019; 25(11): 1398-1408
Published online Mar 21, 2019. doi: 10.3748/wjg.v25.i11.1398
Published online Mar 21, 2019. doi: 10.3748/wjg.v25.i11.1398
Figure 1 Patient disposition.
CHB: Chronic hepatitis B; HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; HBeAg: Hepatitis B e antigen; HIV: Human immunodeficiency virus.
- Citation: Mak LY, To WP, Wong DKH, Fung J, Liu F, Seto WK, Lai CL, Yuen MF. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients. World J Gastroenterol 2019; 25(11): 1398-1408
- URL: https://www.wjgnet.com/1007-9327/full/v25/i11/1398.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i11.1398